Socioeconomic inequalities in lung cancer - a time trend analysis with German health insurance data.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
19 03 2021
Historique:
received: 13 11 2020
accepted: 07 03 2021
entrez: 20 3 2021
pubmed: 21 3 2021
medline: 22 5 2021
Statut: epublish

Résumé

Lung Cancer (LC) is one of the most prevalent cancer diseases. Due to the lack of databases which allow the combination of information on individual socioeconomic status (SES) and cancer incidence, research on social inequalities in LC among the German population is rare. The aim of the study is to analyse time trends in social inequalities in LC in Germany. The analyses are based on data of a large statutory health insurance provider. The data contain information on diagnoses, occupation and education (working age), and income (full age range) of the insurance population. Trends were analysed for two subpopulations (retirement age and working age) and stratified by sex. The analyses are based on incidence rates and proportional hazard models spanning the periods 2006-2009, 2010-2013 and 2014-2017. Incidence rates declined in men but increased in women. For men, inequalities were strongest in terms of income and the decline in incidence was most pronounced in middle- and higher-income men. Among women at retirement age, a reversed income gradient was found which disappeared in the second period. The educational gradient among the working-age population decreased over time due to the trend towards increasing incidence among individuals with higher education. Declining gradients were also found for occupational position. The findings reveal considerable inequalities in LC and that trends vary with respect to SES, sex and age. Widening income inequalities were found in the retired population, while educational and occupational inequalities tend to narrow among the working-age population.

Sections du résumé

BACKGROUND
Lung Cancer (LC) is one of the most prevalent cancer diseases. Due to the lack of databases which allow the combination of information on individual socioeconomic status (SES) and cancer incidence, research on social inequalities in LC among the German population is rare. The aim of the study is to analyse time trends in social inequalities in LC in Germany.
METHODS
The analyses are based on data of a large statutory health insurance provider. The data contain information on diagnoses, occupation and education (working age), and income (full age range) of the insurance population. Trends were analysed for two subpopulations (retirement age and working age) and stratified by sex. The analyses are based on incidence rates and proportional hazard models spanning the periods 2006-2009, 2010-2013 and 2014-2017.
RESULTS
Incidence rates declined in men but increased in women. For men, inequalities were strongest in terms of income and the decline in incidence was most pronounced in middle- and higher-income men. Among women at retirement age, a reversed income gradient was found which disappeared in the second period. The educational gradient among the working-age population decreased over time due to the trend towards increasing incidence among individuals with higher education. Declining gradients were also found for occupational position.
CONCLUSION
The findings reveal considerable inequalities in LC and that trends vary with respect to SES, sex and age. Widening income inequalities were found in the retired population, while educational and occupational inequalities tend to narrow among the working-age population.

Identifiants

pubmed: 33740928
doi: 10.1186/s12889-021-10576-4
pii: 10.1186/s12889-021-10576-4
pmc: PMC7977592
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

538

Subventions

Organisme : AOK Niedersachsen
ID : NA
Organisme : Deutsche Forschungsgemeinschaft
ID : GE 1167/15-1

Références

Tob Control. 2008 Aug;17(4):248-55
pubmed: 18483129
Eur J Public Health. 2015 Aug;25(4):706-10
pubmed: 25505018
PLoS One. 2014 Oct 20;9(10):e109706
pubmed: 25329578
JAMA. 2005 Dec 14;294(22):2879-88
pubmed: 16352796
Public Health. 2018 Jan;154:1-10
pubmed: 29128730
Front Oncol. 2018 Sep 25;8:402
pubmed: 30319967
PLoS One. 2020 Nov 20;15(11):e0242433
pubmed: 33216766
J Epidemiol Community Health. 2011 Jun;65(6):491-6
pubmed: 21071560
N Engl J Med. 2014 Jan 2;370(1):60-8
pubmed: 24382066
Health Stat Q. 2007 Winter;(36):24-35
pubmed: 18092540
Cancer Med. 2016 Sep;5(9):2649-56
pubmed: 27356493
J Epidemiol Community Health. 2006 Sep;60(9):804-10
pubmed: 16905727
Int J Cancer. 2017 Mar 15;140(6):1306-1316
pubmed: 27925183
Prev Chronic Dis. 2012;9:E122
pubmed: 22765931
Z Gerontol Geriatr. 2019 Feb;52(Suppl 1):91-99
pubmed: 30569288
Soc Sci Med. 2015 Feb;127:41-50
pubmed: 25037853
BMJ Open. 2015 May 11;5(5):e006588
pubmed: 25967987
BMC Public Health. 2021 Feb 1;21(1):259
pubmed: 33526035
Biomed Res Int. 2015;2015:370274
pubmed: 26273613
J Thorac Oncol. 2015 Feb;10(2):256-63
pubmed: 25376515
J Epidemiol Community Health. 2015 May;69(5):432-41
pubmed: 25631857
PLoS One. 2020 Jan 16;15(1):e0227541
pubmed: 31945102
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Mar;56(3):447-54
pubmed: 23334292
J Epidemiol Community Health. 2020 Jun;74(7):592-597
pubmed: 32277000
Tob Control. 2012 Mar;21(2):96-101
pubmed: 22345230
J Environ Public Health. 2012;2012:961724
pubmed: 22719777
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Jan;61(1):7-19
pubmed: 28980028
Addiction. 2006 Jul;101(7):1051-6
pubmed: 16771897
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Nov;61(11):1365-1376
pubmed: 30215104
BMC Cancer. 2014 Feb 13;14:87
pubmed: 24524213
BMC Cancer. 2015 Dec 16;15:945
pubmed: 26675142
Int J Environ Res Public Health. 2016 Mar 25;13(4):362
pubmed: 27023582
N Engl J Med. 2013 Jan 24;368(4):351-64
pubmed: 23343064
Popul Res Policy Rev. 2017 Jun;36(3):309-330
pubmed: 29056801
Annu Rev Sociol. 2010 Aug;36:349-370
pubmed: 21909182

Auteurs

Fabian Tetzlaff (F)

Institute for General Practice, Hannover Medical School, Hanover, Germany. tetzlaff.fabian@mh-hannover.de.

Jelena Epping (J)

Medical Sociology Unit, Hannover Medical School, Hanover, Germany.
Comprehensive Cancer Center Hannover, Hannover Medical School, Hanover, Germany.

Juliane Tetzlaff (J)

Medical Sociology Unit, Hannover Medical School, Hanover, Germany.

Heiko Golpon (H)

Department of Pneumology, Hannover Medical School, Hanover, Germany.

Siegfried Geyer (S)

Medical Sociology Unit, Hannover Medical School, Hanover, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH